Results 151 to 160 of about 30,955 (215)

Secondary Angle Closure Glaucoma due to Massive Subretinal and Suprachoroidal Hemorrhage in Neovascular Age-Related Macular Degeneration: Clinical Case and Literature Review. [PDF]

Case Rep Ophthalmol Med
Nagaoka K, Makino S, Inoda S, Kaburaki T.   +3 more
europepmc   +1 more source

Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Tamai R, Nizawa T, Kawamata Y, Iwase T, Baba T.   +4 more
europepmc   +1 more source

A thematic analysis of patients' experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD). [PDF]

Eye (Lond)
Hapeshi J, Hughes S, McKibbin M, Scanlon PH.   +3 more
europepmc   +1 more source

Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trial. [PDF]

Trials
Hanson RLW, Airody A, Saad A, Gale RP.
europepmc   +1 more source

Impaired Vagal Tone Function-Based Regulation of Systemic Inflammation in Patients With Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Molbech CR, Bøegh MM, Nielsen MK, Subhi Y, Liisborg C, Roubeix C, Sennlaub F, Mehlsen J, Sørensen TL.   +8 more
europepmc   +1 more source

Consensus of Expert Recommendations for the Safe Administration of Brolucizumab in Neovascular Age-related Macular Degeneration. [PDF]

Korean J Ophthalmol
Song JR, Park KH, Kang SW, Chin HS, Yu SY, Park YH, Kim YC, Lee JE, Lim ST, Kim JG, Kim CR, Sagong M, Oh HS, Lee CS, Woo SJ.   +14 more
europepmc   +1 more source

Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. [PDF]

Br J Ophthalmol
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, Viggiano P, Peronetti M, Toscani R, Boscia G, Termite AC, Gennaro C, Marolo P, Boscia F, Bandello F, Reibaldi M.   +15 more
europepmc   +1 more source

Proteomic profiles in the aqueous following anti-vegf therapy in treatment naïve neovascular age-related macular degeneration. [PDF]

Clin Proteomics
Lynch AM, Drolet DW, Trinder KM, Gupta S, Westacott MJ, Janjic N, Palestine AG, Patnaik JL, Mathias MT, Mandava N, Wagner BD.   +10 more
europepmc   +1 more source

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network.   +21 more
europepmc   +1 more source

DERIVATION OF A SHORT FORM OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. [PDF]

Retina
Singerman L, Gugiu C, Tschosik E, Doll H, Singerman B, Gentile B.   +5 more
europepmc   +1 more source